South Korea will allocate 194.4 billion won for the development of robot technology next year, up 32 percent from 2020, to have robots play bigger roles assisting workers through 2022, and have them operate autonomously by 2026.
The country plans to lift a set of regulations to pave the way for local firms to develop customized robots for four major areas, namely the industry, commerce, medical, and public sectors.
South Korea's robot industry is expected to reach 20 trillion won in 2025, up from around 5.8 trillion won in 2018, to become among the world's top four players.
The number of local professional robot companies could increase to 20 from just six in 2018.
The country has already kicked off efforts to revise 33 sets of related regulations in different industries.
According to Prime Minister Chung Sye-kyun, South Korea will adjust unnecessary regulations that may hinder the utilization of robots in different industries.
Among the regulations to be introduced are those allowing self-driving delivery robots to run on sidewalks by 2025, providing subsidies on the acquisition of caretaker robots by 2024, setting new rules for valet parking robots, and establishing safety standards for robots deployed in disinfection efforts.


Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Instagram Outage Disrupts Thousands of U.S. Users
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



